The recommended suitability criteria by ASTRO were as follows: age ≥50 years, surgical margin ≥2 mm, Tis or T1, partial ductal carcinoma in situ, ER (+), and no LVSI, invasive lobular carcinoma, or other pathological factors (37). The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.